Role of nitric oxide and WNK-SPAK/OSR1-KCC2 signaling in daily changes in GABAergic inhibition in the rat dorsal raphe neurons
- 1 June 2018
- journal article
- research article
- Published by Elsevier in Neuropharmacology
- Vol. 135, 355-367
Abstract
No abstract availableKeywords
Funding Information
- National Research Foundation of Korea
- Korean government (2011-0030072, 2011-0011939)
This publication has 49 references indexed in Scilit:
- Nitric oxide in the regulation of the sleep-wake statesSleep Medicine Reviews, 2012
- SPAK/OSR1 regulate NKCC1 and WNK activity: analysis of WNK isoform interactions and activation by T-loop trans-autophosphorylationBiochemical Journal, 2011
- WNK2 Kinase Is a Novel Regulator of Essential Neuronal Cation-Chloride CotransportersJournal of Biological Chemistry, 2011
- Phosphoregulation of the Na–K–2Cl and K–Cl cotransporters by the WNK kinasesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2010
- Sites of Regulated Phosphorylation that Control K-Cl Cotransporter ActivityCell, 2009
- Nitric oxide in the central nervous system: neuroprotection versus neurotoxicityNature Reviews Neuroscience, 2007
- WNK4 kinase is a negative regulator of K+-Cl−cotransportersAmerican Journal of Physiology-Renal Physiology, 2007
- Nitric oxide and sleepSleep Medicine Reviews, 2005
- Human Hypertension Caused by Mutations in WNK KinasesScience, 2001
- Axonal and somato‐dendritic modalities of serotonin release: their involvement in sleep preparation, triggering and maintenanceJournal of Sleep Research, 1992